-transparent.png){kind=logo}
The capacity of Ehrlich ascites tumour cells to take up 2-deoxy-D-glucose and to bind cytochalasin B varies adaptatively with the level of glucose in the plasma or culture medium. The effect of glucose is exerted directly on the cells and does not necessarily require the participation of hormones such as insulin, glucagon or corticosterone, although glucagon and the glucocorticoids, but not insulin, can also increase the number of glucose carrier molecules administered in vitro. Cycloheximide suppresses the acute inductive effect of glucose, suggesting that protein synthesis might be required for the increased transport activity.
Related Publications
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
February 1976,
The Biochemical journal,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
August 1976,
The Biochemical journal,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
December 1993,
Chemical & pharmaceutical bulletin,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
October 1976,
The Biochemical journal,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
February 1988,
Biochemistry international,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
May 1983,
The Journal of physiology,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
May 1983,
Scandinavian journal of clinical and laboratory investigation,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
September 1977,
Biochimica et biophysica acta,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
May 1973,
Nature: New biology,
K P Fung, and
Y M Choy, and
T W Chan, and
W P Lam, and
C Y Lee
February 1977,
Biochemical pharmacology,
